Search Results 761-770 of 17169 for monoclonal antibody

  1. Acute Myelogenous Leukemia Clinical Trials

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  2. Model Clarifies Immunotherapy for Multiple Myeloma - Mayo Clinic News Network

    The authors report that the mouse model helped evaluate different ways to combine standard chemotherapies with the antibody drugs. They evaluated toxicity ...

  3. 1 Mayo Family Medicine Rochester Publications 2021 Journal publications with Family Medicine clinicians. Family Medicine authors

    A Mobile Unit Overcomes the Challenges to Monoclonal Antibody Infusion for COVID-. 19 in Skilled Care Facilities. J Am Geriatr Soc 2021;69(4):868-873. 66 ...

  4. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    ... monoclonal antibody against LOXL2, in patients with IPF. Read More on PubMed. Additional contact information. Non-cancer trials contact form. Phone: 800-664 ...

  5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

  6. Publications - Alicia Algeciras-Schimnich, Ph.D. - Mayo Clinic

    Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays. ... Thyroglobulin and thyroglobulin antibody ...

  7. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody and B-cell maturation antigen (BCMA)-directed therapy * Cohort D: Newly diagnosed multiple myeloma per IMWG with a history of 4 to 8 ...

  8. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303) - Mayo Clinic

    The purpose of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / PD-L1 bispecific antibody SPX- 303 in patients with ...

  9. Convalescent Plasma: A Therapy for COVID-19? - Mayo Clinic News Network

    One potential treatment that has garnered attention is known as convalescent plasma therapy. The approach involves giving patients an infusion of antibody-rich ...

  10. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions - Mayo Clinic

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...